A
A. Tye
Researcher at Ohio State University
Publications - 35
Citations - 486
A. Tye is an academic researcher from Ohio State University. The author has contributed to research in topics: Ephedrine & Norepinephrine (medication). The author has an hindex of 11, co-authored 35 publications receiving 479 citations.
Papers
More filters
Journal ArticleDOI
Steric Aspects of Adrenergic Drugs
TL;DR: In vasa deferentia obtained from reserpine-pretreated rats, tyramine released equal amounts of radioactivity when tissues were either preincubated with (−)- or (+)-isomer, however, the response of vasadeferentia preincUBated with the (−)-isomers was approximately 7-fold greater than of those preincubsated withThe results are discussed in relation to the drug-induced release of the isomers.
Journal Article
Steric aspects of adrenergic drugs. II. Effects of DL isomers and desoxy derivatives on the reserpine-pretreated vas deferens.
TL;DR: The results suggest that the Easson-Stedman hypothesis holds true over a wide range of substances in the catecholamine-depleted preparation but not in the untreated preparation where the dose-response curves of indirectly-acting desoxy derivatives and L(+) isomers appear to be related to their known affinity for catecholinamine uptake sites.
Journal Article
Steric aspects of adrenergic drugs. i. comparative effects of dl isomers and desoxy derivatives
TL;DR: In the article by P. N. Patil, J. B. LaPidus and A. Tye, January 1967, corrections should be made as follows: 1) in figure 2 the definitions for the symbols given on the figure itself are incorrect and the figure legend gives the correct definition for each curve.
Journal Article
A PHARMACOLOGiCAL STUDY OF THE EPHEDRINE ISOMERS
TL;DR: In reserpine pretreated dogs, increased blood pressure and heart rate effects of the isomers were markedly reduced and this reduction was reversible by increased dosage in the case of D (-) -ephedrine,but irreversible for L(+)- ephedrine and L( +)-pseudoephedine.
Journal ArticleDOI
Anti‐metrazol® efficacy of combinations of meparfynol and anticonvulsant drugs
TL;DR: The addition of meparfynol to an anticonvulsant did not cause the protective index to rise above that of the better component in the combination, and the combined drug had no effect on neurotoxicity in mice.